PWM
ABBV icon

Purus Wealth Management’s AbbVie ABBV Stock Holding History

Purus Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Buy
1,247
+45
+4% +$9.68K 0.09% 130
2026
Q1 		$261K Buy
1,202
+27
+2% +$5.99K 0.08% 127
2025
Q4 		$269K Buy
1,175
+15
+1% +$3.42K 0.08% 121
2025
Q3 		$269K Buy
1,160
+8
+0.7% +$1.63K 0.09% 116
2025
Q2 		$214K Buy
+1,152
New +$214K 0.07% 132

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Purus Wealth Management's ABBV Position: Q2 2026 in Review

Purus Wealth Management increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $9.68K and bringing the position to 1,247 shares worth $314K. The position accounts for 0.09% of the portfolio, ranked #130.

Purus Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Purus Wealth Management held 1,247 shares of AbbVie worth $314K as of Q2 2026.
  • Purus Wealth Management bought 45 AbbVie shares in Q2 2026, an estimated $9.68K.
  • AbbVie made up 0.09% of Purus Wealth Management's portfolio in Q2 2026, its #130 holding.
  • Purus Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Purus Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.